X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercebiotech.com/biotech/further-blow-biohaven-fda-refuses-consider-failed-rare-disease-drug-approval
https://www.biopharmadive.com/news/biohaven-adds-to-a-long-list-of-alzheimers-drug-failures/593578/
https://www.globenewswire.com/news-release/2021/01/18/2160200/0/en/MediciNova-Receives-Notice-of-Allowance-for-New-Patent-Covering-the-Combination-of-MN-166-ibudilast-and-Riluzole-for-the-Treatment-of-Amyotrophic-Lateral-Sclerosis-ALS-in-Japan.html
https://www.prnewswire.com/news-releases/biohaven-begins-pivotal-phase-3-trial-of-troriluzole-in-obsessive-compulsive-disorder-301199932.html
https://www.prnewswire.com/news-releases/biohaven-announces-obsessive-compulsive-disorder-ocd-proof-of-concept-phase-23-study-results-and-program-update-301082586.html
https://endpts.com/biohaven-reports-another-trial-failure-for-troriluzole-cyclica-raises-c23m-for-ai-driven-discovery-platform/
https://www.biohavenpharma.com/sites/default/files/documents/Troriluzole_SCA_Phase_IIb-III_Long_Term_Extension_Study_AAN_2019_Poster.pdf
https://in.reuters.com/article/us-biohaven-study/biohaven-anxiety-treatment-fails-late-stage-study-shares-fall-16-idINKBN2041GB
https://www.prnewswire.com/news-releases/biohaven-announces-issuance-of-composition-of-matter-patent-on-troriluzole-by-the-us-patent-and-trademark-office-300970399.html
https://www.prnewswire.com/news-releases/biohaven-completes-enrollment-in-pivotal-phase-23-alzheimers-disease-clinical-trial-of-troriluzole-300951175.html
https://www.prnewswire.com/news-releases/biohaven-enrolls-first-patient-in-phase-3-spinocerebellar-ataxia-clinical-trial-of-troriluzole-300812397.html
https://www.clinicalleader.com/doc/biohaven-completes-enrollment-in-spinocerebellar-ataxia-clinical-trial-with-trigriluzole-0001
Market Place
Share 
